Novo Nordisk reported DKK0.96 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Jun/2026 0.96 0.80 0.93 Aug/04
FY2024Q3 Sep/2024 6.12 0.88 5.00 Nov/06
FY2024Q2 Jun/2024 4.49 4.32 Aug/07
FY2024Q1 Mar/2024 5.68 4.39 May/02
FY2023Q4 Dec/2023 0.72 0.67 6.02 Jan/31




Eps Change Date
ANI Pharmaceuticals USD 2.7 0.49 Sep/2026
Aurora Cannabis CAD -0.07 0.06 Jun/2026
Bausch Health Companies USD 1.77 0.51 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Canopy Growth CAD -0.03 0.37 Jun/2026
Corcept Therapeutics USD 1.01 0.65 Sep/2026
Drreddys Laboratories INR 11.1 11.04 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 2.46 0.05 Sep/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Novo Nordisk DKK 0.96 9.95 Jun/2026
Pacira USD 0.7 0.03 Sep/2026
Perrigo USD 0.6 0.1 Sep/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 0.98 0.25 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
Supernus Pharmaceuticals USD 0.35 1.36 Sep/2026
Zoetis USD 1.75 0.12 Sep/2026